Lakewood Capital Down 31% In Q1: Shorting The Following “Questionable Korean Biotech Companies”
Anthony Bozza's Lakewood Capital Management ended the first quarter of 2020 with a net loss of 31.1%.
According to a copy of the hedge fund's Q1 letter, which ValueWalk has been able to review, the firm ended the month of March with long equity exposure of 98% and short exposure of 39.8% for net exposure of 58.2%. SORRY! This content is exclusively for paying members. If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.
If you’re looking for value stocks, and exclusive access to value-focused hedge fund managers, check out
